The defining structural element that distinguishes BRD3067 from Tubastatin A is the existence of an ortho-methyl group positioned adjacent for the hydroxamic acid moiety on the benzene ring [18]. This ortho-methyl substitution produces sizeable steric hindrance that forestalls the compound from acce